Insider and congress filings
CVS Health Corp. (CVS)
About CVS Health Corp.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Chief executive
- J. David Joyner
- Employees
- 259,500
- Listed since
- -
- Market value
- $121.7B
- Price to earnings
- 24.9
- Earnings per share
- $3.84
- Dividend yield
- 2.79%
Earnings
6 reported quarters · next on Nov 4, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 5, 2026 | $2.58 | $1.87 | $106.1B | $100.0B | EPS beatRevenue beat |
| Q1 FY2026reported May 6, 2026 | $2.57 | $2.21 | $106.1B | $95.0B | EPS beatRevenue beat |
| Q4 FY2025reported Feb 10, 2026 | $1.09 | $1.00 | $105.7B | $103.7B | EPS beatRevenue beat |
| Q3 FY2025reported Oct 29, 2025 | $1.60 | $1.37 | $102.9B | $98.8B | EPS beatRevenue beat |
| Q2 FY2025reported Jul 31, 2025 | $1.81 | $1.46 | $98.9B | $94.5B | EPS beatRevenue beat |
| Q1 FY2025reported May 1, 2025 | $2.25 | $1.70 | $94.6B | $93.7B | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 3, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| J. David JoynerPresident and Chief Executive Officer | $1.5M | $14.5M | $5.1M | $21.2M |
| Prem S. ShahExecutive Vice President and Group President | $1.1M | $7.2M | $5.1M | $13.4M |
| Steven H. NelsonExecutive Vice President and President, Aetna | $1.0M | $5.8M | $4.8M | $11.6M |
| Tilak MandadiExecutive Vice President, Ventures and Chief Experienc | $1.0M | $5.6M | $4.4M | $11.0M |
| Brian O. NewmanExecutive Vice President and Chief Financial Officer | $697K | $5.6M | $3.1M | $9.4M |
The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $12.7B | 123,223,409 | -2.1% | 9.66% |
| Vanguard Capital Management LLC | $8.6B | 83,315,369 | +0.8% | 6.53% |
| Capital World Investors | $7.8B | 74,951,955 | -3.0% | 5.87% |
| State Street Corp | $6.2B | 60,283,408 | +1.6% | 4.72% |
| Dodge & Cox | $5.2B | 50,012,765 | -3.4% | 3.92% |
| Wellington Management Group LLP | $3.5B | 33,801,113 | +49.8% | 2.65% |
| Geode Capital Management, LLC | $3.1B | 29,899,653 | +1.5% | 2.34% |
| FMR LLC | $3.0B | 28,920,617 | -7.3% | 2.27% |
| Vanguard Portfolio Management LLC | $2.8B | 26,637,259 | +2.5% | 2.09% |
| Capital Research Global Investors | $2.5B | 24,329,151 | +21.6% | 1.91% |
| Price T Rowe Associates Inc | $2.5B | 24,203,884 | +1.8% | 1.90% |
| Bank Of America Corp | $2.4B | 23,188,670 | +148.0% | 1.82% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
8 filings of 358 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Larry RobbinsDirector | Sold · 2 lines | 748,462 | $75.69 | $56.7M | May 21, 2026 | 0d |
| Larry RobbinsDirector | Sold · 4 lines | 1,018,000 | $93.82 | $95.5M | May 20, 2026 | 1d |
| Larry RobbinsDirector | Sold · 2 lines | 1,983,538 | $94.45 | $187.3M | May 19, 2026 | 2d |
| Tilak MandadiEVP, Chief Exp & Tech Officer | Sold | 69,551 | $89.58 | $6.2M | May 8, 2026 | 3d |
| Steven H. NelsonEVP and President, Aetna | Bought | 24 | $53.70 | $1K | Jan 23, 2025 | 369d |
| Heidi B. CapozziEVP and Chief People Officer | Bought | 35 | $56.85 | $2K | Oct 23, 2024 | 356d |
| Heidi B. CapozziEVP and Chief People Officer | Bought | 10 | $62.24 | $622 | Oct 2, 2024 | 377d |
| Heidi B. CapozziEVP and Chief People Officer | Bought | 35 | $56.47 | $2K | Sep 9, 2024 | 400d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in CVS
20 disclosures of 260 on record · median 22d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +1.4%S&P -0.1% · vs S&P 500 +1.5% | Aug 24, 2026 | Sep 4, 2026 | 11d |
| Alan ArmstrongSelfFiled late | Stock | Purchase | $1,001 - $15,000 | +36.1%S&P +20.2% · vs S&P 500 +15.9% | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +6.6%S&P +0.4% · vs S&P 500 +6.2% | Jun 2, 2026 | Jul 6, 2026 | 34d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +16.2%S&P +5.8% · vs S&P 500 +10.4% | May 1, 2026 | Jun 9, 2026 | 39d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -0.5%S&P +3.2% · vs S&P 500 -3.7% | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +22.1%S&P +11.1% · vs S&P 500 +11.0% | Apr 13, 2026 | May 11, 2026 | 28d |
| Michael T. McCaul | Stock | Purchase | $15,001 - $50,000 | +23.7%S&P +10.7% · vs S&P 500 +13.0% | Feb 20, 2026 | Mar 10, 2026 | 18d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +28.6%S&P +10.9% · vs S&P 500 +17.7% | Feb 24, 2026 | Mar 9, 2026 | 13d |
| John BoozmanJoint | Stock | Purchase | $1,001 - $15,000 | +28.1%S&P +9.8% · vs S&P 500 +18.3% | Jan 29, 2026 | Feb 15, 2026 | 17d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | +17.6%S&P +10.0% · vs S&P 500 +7.6% | Jan 13, 2026 | Feb 11, 2026 | 29d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +28.1%S&P +9.8% · vs S&P 500 +18.3% | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Dwight Evans | Stock | Sale | $1,001 - $15,000 | +22.2%S&P +15.7% · vs S&P 500 +6.6% | Nov 21, 2025 | Dec 19, 2025 | 28d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +22.1%S&P +11.8% · vs S&P 500 +10.3% | Oct 31, 2025 | Nov 21, 2025 | 21d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +23.7%S&P +12.3% · vs S&P 500 +11.4% | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +23.7%S&P +12.3% · vs S&P 500 +11.4% | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | +15.1%S&P +11.4% · vs S&P 500 +3.6% | Oct 27, 2025 | Nov 10, 2025 | 14d |
| Val T. HoyleSpouse | Stock | Sale | $1,001 - $15,000 | +24.7%S&P +14.6% · vs S&P 500 +10.1% | Sep 23, 2025 | Oct 10, 2025 | 17d |
| Val T. HoyleSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +69.6%S&P +31.1% · vs S&P 500 +38.5% | Oct 29, 2024 | Sep 12, 2025 | 318d |
| Michael T. McCaul | Stock | Sale | $50,001 - $100,000 | +33.1%S&P +18.3% · vs S&P 500 +14.7% | Aug 22, 2025 | Sep 11, 2025 | 20d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +55.2%S&P +20.8% · vs S&P 500 +34.4% | Aug 4, 2025 | Sep 9, 2025 | 36d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
9 members · estimate, as of Sep 10, 20269 members report a position (estimated). The largest estimated position is in the $50,001 - $100,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Harriet M. Hageman | Republican · House | $50,001 - $100,000 | 3.0% |
| Sheldon Whitehouse | Democrat · Senate | $50,001 - $100,000 | 0.3% |
| Derek Tran | Democrat · House | $15,001 - $50,000 | 8.1% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $15,001 - $50,000 | 0.1% |
| Gary C. Peters | Democrat · Senate | $15,001 - $50,000 | 0.5% |
| Shelley Moore Capito | Republican · Senate | $15,001 - $50,000 | 0.7% |
| John Boozman | Republican · Senate | $1,001 - $15,000 | 0.4% |
| Dwight Evans | Democrat · House | $1,001 - $15,000 | 6.2% |
| Robert Bresnahan | Republican · House | $1,001 - $15,000 | 0.1% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| James David ClarkSVP, Cont & Chief Acct Officer | Tax withholding | 454 | Jun 26, 2026 |
| Brian NewmanEVP, Chief Financial Officer | Tax withholding | 2,478 | May 31, 2026 |
| Amy Compton-PhillipsEVP, Chief Medical Officer | Tax withholding | 7,618 | May 31, 2026 |
| Fernando AguirreDirector | Disposed to issuer | 30,437 | May 20, 2026 |
| Fernando AguirreDirector | Disposed to issuer | 1,563 | May 21, 2026 |
| Michael F. MahoneyDirector | Stock award | 3,474 | May 14, 2026 |
| Guy P. SansoneDirector | Stock award | 1,447 | May 14, 2026 |
| C. David Brown IIDirector | Stock award | 1,544 | May 14, 2026 |
| Larry RobbinsDirector | Stock award | 3,860 | May 14, 2026 |
| Leslie V. NorwalkDirector | Stock award | 1,447 | May 14, 2026 |
| J. Scott KirbyDirector | Stock award | 1,447 | May 14, 2026 |
| Jeffrey R. BalserDirector | Stock award | 2,058 | May 14, 2026 |
| John E. GallinaDirector | Stock award | 2,895 | May 14, 2026 |
| Anne A. FinucaneDirector | Stock award | 3,088 | May 14, 2026 |
| Douglas H. ShulmanDirector | Stock award | 2,895 | May 14, 2026 |
| Alecia A. DecoudreauxDirector | Stock award | 2,895 | May 14, 2026 |
| Fernando AguirreDirector | Stock award | 1,563 | May 14, 2026 |
| Samrat S. KhichiEVP, CPO and General Counsel | Tax withholding | 3,541 | Apr 1, 2026 |
| Prem S. ShahEVP and Group President | Stock award | 186,738 | Mar 31, 2026 |
| Prem S. ShahEVP and Group President | Tax withholding | 1,484 | Apr 1, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling CVS?
Across the 8 most recent open-market filings shown here, 4 were purchases and 4 were sales.
Which members of Congress have traded CVS?
Ro Khanna, Alan Armstrong, Michael T. McCaul, John Boozman, Dwight Evans, Lisa C. McClain and others disclosed CVS transactions in the filings shown here.
Which members of Congress hold CVS?
9 members of Congress report a position in CVS in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Harriet M. Hageman, Sheldon Whitehouse and Derek Tran. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is CVS in the S&P 500 or the Nasdaq 100?
CVS Health Corp. is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are CVS trades disclosed?
Insider filings on this page reached the public a median of 356 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 22 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.